Retraction notice to “Differentiation of human iPSCs into VSMCs and generation of VSMC-derived calcifying vascular cells” [Stem Cell Res. 31 (2018) 62–70]

Retraction notice to “Differentiation of human iPSCs into VSMCs and generation of VSMC-derived calcifying vascular cells” [Stem Cell Res. 31 (2018) 62–70]

Bibliographic Details
Main Authors:	Anja Trillhaase, Undine Haferkamp, Alexandra Rangnau, Marlon Märtens, Beatrice Schmidt, Michaela Trilck, Philip Seibler, Redouane Aherrahrou, Jeanette Erdmann, Zouhair Aherrahrou
Format:	Article
Language:	English
Published:	Elsevier 2020-05-01
Series:	Stem Cell Research
Online Access:	http://www.sciencedirect.com/science/article/pii/S1873506120301318

Similar Items

Differentiation of human iPSCs into VSMCs and generation of VSMC-derived calcifying vascular cells
by: Anja Trillhaase, et al.
Published: (2018-08-01)

The CAD risk locus 9p21 increases the risk of vascular calcification in an iPSC-derived VSMC model
by: Anja Trillhaase, et al.
Published: (2021-03-01)

Dare to Compare. Development of Atherosclerotic Lesions in Human, Mouse, and Zebrafish
by: Viviana L. Vedder, et al.
Published: (2020-06-01)

iPSCs are safe!
by: Hualong Yan, et al.
Published: (2017-05-01)

Effect of Differences in the Microbiome of <i>Cyp17a1</i>-Deficient Mice on Atherosclerotic Background
by: Axel Künstner, et al.
Published: (2021-05-01)

iPSCs in Modeling and Therapy of Osteoarthritis
by: Maria Csobonyeiova, et al.
Published: (2021-02-01)

Applications of iPSCs in Cancer Research
by: Jean J. Kim
Published: (2015-01-01)

Applications of iPSCs in Cancer Research
by: Jean J. Kim
Published: (2015-07-01)

Phenotyping Neurodegeneration in Human iPSCs
by: Li, Jonathan, et al.
Published: (2021)

Parallel derivation of X-monosomy induced pluripotent stem cells (iPSCs) with isogenic control iPSCs
by: Anis Feki, et al.
Published: (2020-08-01)

Targeted Integration of Inducible Caspase-9 in Human iPSCs Allows Efficient <i>in vitro</i> Clearance of iPSCs and iPSC-Macrophages
by: Alexandra Lipus, et al.
Published: (2020-04-01)

Células Estaminais Pluripotentes Induzidas (iPSCs)
by: Mariana da Costa Santos Coelho Freitas
Published: (2019)

Differentiation of human iPSCs into functional podocytes.
by: Caroline Rauch, et al.
Published: (2018-01-01)

iPSCs: From Bench to Clinical Bed
by: Yujing Li, et al.
Published: (2016-01-01)

sGC Activity and Regulation of Blood Flow in a Zebrafish Model System
by: Krishan K. Vishnolia, et al.
Published: (2021-02-01)

Pedagogical Tools in the 21st Century
by: Meryem Aherrahrou
Published: (2017-08-01)

The Potential of iPSCs for the Treatment of Premature Aging Disorders
by: Claudia Compagnucci, et al.
Published: (2017-11-01)

Nanog-Independent Reprogramming to iPSCs with Canonical Factors
by: Ava C. Carter, et al.
Published: (2014-02-01)

Disease, iPSCs and a Quest for the Perfect Model
Published: (2016-02-01)

Broader Implications of Defining Standards for the Pluripotency of iPSCs
by: Daley, George Q., et al.
Published: (2015)

Studies in Zebrafish Demonstrate That CNNM2 and NT5C2 Are Most Likely the Causal Genes at the Blood Pressure-Associated Locus on Human Chromosome 10q24.32
by: Krishan K. Vishnolia, et al.
Published: (2020-09-01)

Deficiency in MT5-MMP Supports Branching of Human iPSCs-Derived Neurons and Reduces Expression of GLAST/S100 in iPSCs-Derived Astrocytes
by: Nikita Arnst, et al.
Published: (2021-07-01)

Microhomology-assisted scarless genome editing in human iPSCs
by: Shin-Il Kim, et al.
Published: (2018-03-01)

Protocol for Differentiation of Human iPSCs into Pulmonary Neuroendocrine Cells
by: Pooja Hor, et al.
Published: (2020-09-01)

Apoptosis in Porcine Pluripotent Cells: From ICM to iPSCs
by: Eunhye Kim, et al.
Published: (2016-09-01)

The State of Play with iPSCs and Spinal Cord Injury Models
by: Stuart I. Hodgetts, et al.
Published: (2015-01-01)

An Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCs
by: Siddharth Menon, et al.
Published: (2016-01-01)

Modeling anthracycline-induced cardiotoxicity with patient-specific iPSCs
by: Haupt, Luis Peter
Published: (2018)

Pannexin 1 Influences Lineage Specification of Human iPSCs
by: Rebecca J. Noort, et al.
Published: (2021-04-01)

iPSCs and Exosomes: Partners in Crime Fighting Cardiovascular Diseases
by: Giulia Germena, et al.
Published: (2021-06-01)

Generation and characterization of eight human-derived iPSC lines from affected and unaffected THAP1 mutation carriers
by: Hauke Baumann, et al.
Published: (2018-12-01)

Induced pluripotent stem cells (iPSCs) for research and therapy : induction of hepatic differentiation in iPSCs and evaluation of their quality as a model of in vivo development in the context of coagulation
by: Caxaria, Sara
Published: (2016)

Dissecting transcriptomic signatures of neuronal differentiation and maturation using iPSCs
by: Emily E. Burke, et al.
Published: (2020-01-01)

Studying leukemia stem cell properties and vulnerabilities with human iPSCs
by: Nikolaos Spyrou, et al.
Published: (2021-01-01)

Subtype-Directed Differentiation of Human iPSCs into Atrial and Ventricular Cardiomyocytes
by: Mandy Kleinsorge, et al.
Published: (2020-06-01)

Recent Overview of the Use of iPSCs Huntington’s Disease Modeling and Therapy
by: Maria Csobonyeiova, et al.
Published: (2020-03-01)

Naive-like ESRRB+ iPSCs with the Capacity for Rapid Neural Differentiation
by: Fumihiko Kisa, et al.
Published: (2017-12-01)

The Application of Human iPSCs in Neurological Diseases: From Bench to Bedside
by: Nina Xie, et al.
Published: (2016-01-01)

Derivation and molecular characterization of pancreatic differentiated MODY1-iPSCs
by: Carmel Braverman-Gross, et al.
Published: (2018-08-01)

Establishing iPSCs as a method to model neurodevelopment in Down’s syndrome
by: Bartish, Margarita
Published: (2012)